Short answer · Medically reviewed summary · Last updated: 2026-04-07
The primary ICD-10-CM code for Hypokalemic periodic paralysis is G72.3, which covers periodic paralysis, while the legacy ICD-9-CM code used for this condition is 359.3. These diagnostic codes are essential for medical billing, insurance authorization, and clinical documentation for patients living with this rare channelopathy. What is Hypokalemic periodic paralysis? Hypokalemic periodic paralysis is a rare, autosomal dominant neuromuscular disorder characterized by recurrent episodes of muscle weakness or paralysis, typically associated with low serum potassium levels.
The primary ICD-10-CM code for Hypokalemic periodic paralysis is G72.3, which covers periodic paralysis, while the legacy ICD-9-CM code used for this condition is 359.3. These diagnostic codes are essential for medical billing, insurance authorization, and clinical documentation for patients living with this rare channelopathy.
Hypokalemic periodic paralysis is a rare, autosomal dominant neuromuscular disorder characterized by recurrent episodes of muscle weakness or paralysis, typically associated with low serum potassium levels. These episodes can last from a few hours to several days and often involve profound weakness that may lead to temporary inability to move. Because Hypokalemic periodic paralysis affects the ion channels in muscle cell membranes, patients often experience these attacks following heavy carbohydrate meals, strenuous exercise followed by rest, or periods of emotional stress. Currently, 31 individuals with Hypokalemic periodic paralysis have joined the DiseaseMaps.org community to share their experiences and support one another through the challenges of this chronic condition.
Accurate coding is vital for patients navigating the healthcare system with Hypokalemic periodic paralysis. Medical professionals use specific classification systems to track the prevalence and clinical management of the disorder.
In the majority of cases, Hypokalemic periodic paralysis is inherited in an autosomal dominant pattern, meaning a child of an affected parent has a 50% chance of inheriting the genetic mutation. The condition is most commonly caused by mutations in the CACNA1S gene (approximately 60% of cases) or the SCN4A gene. It is important for families to consult with a clinical geneticist to understand the specific mutation involved, as this can influence the clinical presentation and treatment response for Hypokalemic periodic paralysis. While some cases appear sporadically, clinical genetic testing is the gold standard for confirmation.
Living with Hypokalemic periodic paralysis requires a multidisciplinary approach. Management often focuses on preventing attacks through diet, medication, and lifestyle adjustments. Keeping a detailed log of triggers—such as dietary intake, sleep patterns, and physical activity—is highly recommended to share with your specialist. Because the condition is rare, finding a neurologist with expertise in neuromuscular channelopathies is crucial for developing an effective, personalized care plan that addresses both the physical symptoms and the psychological impact of living with a fluctuating, unpredictable illness.
Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.